Responding to requests from adult patients for neuroenhancements Guidance of the Ethics, Law and Humanities Committee
Responding to requests from adult patients for neuroenhancements Guidance of the Ethics, Law and Humanities Committee
复制标题
DOI：
10.1212/wnl.0b013e3181beecfe
复制
发表时间：
2009-10-27
期刊：
影响因子：
9.9
通讯作者：
Bonnie, Richard J.
中科院分区：
文献类型：
--
作者：
Larriviere, Dan;Williams, Michael A.;Bonnie, Richard J.
在过去的十年里，没有确诊的医疗或精神健康状况的人越来越多地寻求和使用处方药，表面上是为了增强他们的记忆或认知技能，这些处方药最初是为了改善被诊断患有注意力缺陷多动障碍或阿尔茨海默病等疾病的人的执行功能或记忆而开发的。有证据表明，这种现在被称为神经强化的做法正在积聚势头。因此，神经学家可能会遇到没有确诊疾病的患者要求药物治疗，目的是改善他们的记忆力、认知注意力或注意力持续时间。支持和反对这一做法的人都有强烈的论点，这往往反映了人们对适当的医学实践的坚定信念。这份报告的目的是为神经科医生提供关于使用药物来增强或增强正常认知或情感功能的伦理、法律和社会问题的概述，以及回应成年患者神经增强请求的实用指导。神经病学(R)2009；73：1406-1412
In the last decade, persons who have no diagnosed medical or mental health condition are increasingly seeking and utilizing, for the ostensible purpose of enhancing their memory or cognitive skills, prescription drugs that were originally developed to improve executive function or memory in persons diagnosed with disorders such as attention deficit hyperactivity disorder or Alzheimer disease. Evidence suggests that this practice, now known as neuroenhancement, is gathering momentum. As a result, neurologists may be encountering patients without a diagnosed illness asking for medications with the goal of improving their memory, cognitive focus, or attention span. Strong arguments have been made for and against this practice, often reflecting strongly held convictions concerning the appropriate practice of medicine. The purpose of this report is to provide neurologists with an overview of the ethical, legal, and social issues surrounding the use of pharmaceuticals prescribed to enhance or augment normal cognitive or affective functioning, as well as practical guidance for responding to an adult patient's request for neuroenhancement. Neurology (R) 2009;73:1406-1412